CCL5 and breast cancer: Breast cancer cells promote the synthesis of CCL5 (also called RANTES) from MSCs by communicating with C-C chemokine receptor type 5, enhancing cancer cell motility, invasion, and distant spread in vitro and in vivo (Karnoub et al., 2007).